1. The PMHNP is caring for a patient with schizophrenia and is considering a variety of treatment approaches. The PHMNP selects a viable treatment that is consistent with the “dopamine hypothesis of schizophrenia.” What action does the PMHNP anticipate this treatment having on the patient?
A.
Blocking the release of dopamine facilitates the onset of positive schizophrenia symptoms.
B.
Hyperactivity in the mesolimbic dopamine pathway mediates the positive symptoms of schizophrenia.
C.
Antipsychotic drugs that open D2 receptor pathways can treat schizophrenia.
D.
The neuroanatomy of dopamine neuronal pathways can explain symptoms of schizophrenia.